Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 205917
Company: HIKMA PHARMS

Products on NDA 205917

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
PARICALCITOL	PARICALCITOL	0.002MG/ML (0.002MG/ML)	SOLUTION;INTRAVENOUS	Discontinued	None	No	No
PARICALCITOL	PARICALCITOL	0.005MG/ML (0.005MG/ML)	SOLUTION;INTRAVENOUS	Discontinued	None	No	No
PARICALCITOL	PARICALCITOL	0.01MG/2ML (0.005MG/ML)	SOLUTION;INTRAVENOUS	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 205917

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/18/2014	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205917s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/205917Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205917Orig1s000TOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/17/2026	SUPPL-3	Labeling-Package Insert	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/205917Orig1s003ltr.pdf

Labels for NDA 205917

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
11/18/2014	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205917s000lbl.pdf